Related Experiment Video
Updated: Sep 30, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
CB1 cannabinoid receptor-mediated tyrosine phosphorylation of focal adhesion kinase-related non-kinase
1Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40292, USA.
Abstract:
The effect of cannabinoid on the tyrosine phosphorylation of focal adhesion kinase (FAK) and focal adhesion kinase-related non-kinase (FRNK) was investigated in differentiated mouse neuroblastoma N1E-115 cells. HU-210, a potent cannabinoid agonist, elicited a time-dependent enhancement of tyrosine phosphorylation of FRNK, but not FAK. Pretreatment of cells with antisense oligodeoxynucleotide targeting CB1 cannabinoid receptor abolished HU-210-induced FRNK tyrosine phosphorylation. In addition, pretreatment of cells with 8-Br-cAMP also blocked HU-210-induced FRNK tyrosine phosphorylation. These data demonstrated that HU-210 induces FRNK tyrosine phosphorylation by activating G(i)-coupled CB1 cannabinoid receptor in N1E-115 cells. This newly discovered, cannabinoid-induced FRNK tyrosine phosphorylation might be a novel mechanism for cannabinoid-induced functional changes.
Insights
Cannabinoids activate the CB1 receptor to increase tyrosine phosphorylation of FRNK, but not FAK, in neuroblastoma cells. This suggests a new pathway for cannabinoid-induced cellular changes.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Focal adhesion kinase (FAK) and FAK-related non-kinase (FRNK) are key regulators of cell signaling and adhesion.
- Cannabinoids are known to modulate various cellular functions through specific receptors.
Purpose of the Study:
- To investigate the effect of cannabinoids on the tyrosine phosphorylation of FAK and FRNK in differentiated mouse neuroblastoma N1E-115 cells.
- To elucidate the signaling pathway involved in cannabinoid-induced phosphorylation changes.
Main Methods:
- Treatment of N1E-115 cells with HU-210, a cannabinoid agonist.
- Assessment of tyrosine phosphorylation of FAK and FRNK using Western blotting.
- Use of antisense oligodeoxynucleotide targeting the CB1 cannabinoid receptor.
- Inhibition studies using 8-Br-cAMP.
Main Results:
- HU-210 significantly enhanced the tyrosine phosphorylation of FRNK in a time-dependent manner, while FAK phosphorylation remained unaffected.
- The HU-210-induced FRNK tyrosine phosphorylation was abolished by pretreatment with CB1 receptor antisense oligodeoxynucleotide.
- Pretreatment with 8-Br-cAMP also blocked the HU-210-induced FRNK tyrosine phosphorylation.
Conclusions:
- HU-210 activates the G(i)-coupled CB1 cannabinoid receptor to induce FRNK tyrosine phosphorylation in N1E-115 cells.
- This cannabinoid-induced FRNK tyrosine phosphorylation represents a novel signaling mechanism potentially contributing to cannabinoid-mediated functional outcomes.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
MAPK Signaling Cascades
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

